Global Robotic Endoscopy Market Growth, 2031

The global robotic endoscopy market is undergoing rapid evolution, propelled by an increasing clinical transition toward highly precise, minimally invasive diagnostic and therapeutic interventions that enhance reach, dexterity, and visualization within complex anatomical lumens. Renowned professional organizations, such as the Society of American Gastrointestinal and Endoscopic Surgeons (SAGES), the American Gastroenterological Association (AGA), and the American Thoracic Society (ATS), play a pivotal role in advancing market adoption by defining procedural standards, evaluating clinical outcomes, and establishing comprehensive surgeon training and credentialing frameworks. Strict regulatory bodies, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) under the Medical Device Regulation (MDR) framework, exercise detailed oversight across shape-sensing navigation, electromagnetic guidance systems, micro-robotic articulation, and software cybersecurity. Concurrently, national healthcare policies promoting value-based care and dedicated reimbursement codes for robotic-assisted bronchoscopy, colonoscopy, and laparoscopic procedures incentivize health systems to invest in robotic endoscopy infrastructure. Looking ahead, significant future opportunities lie in integrating artificial intelligence for automated path planning, real-time tissue characterization, and computer-assisted lesion detection. Furthermore, the convergence of flexible robotic endoscopes with single-use sterile scope designs to eliminate cross-contamination, along with the development of compact, cost-efficient platforms for ambulatory surgical centers (ASCs) and remote telesurgery applications, presents vast potential for sustained long-term market expansion worldwide. The global robotic endoscopy market features an expanding, highly competitive landscape driven by pioneering medical technology enterprises and specialized digital surgery innovators. Robust market growth is propelled by the rising global demand for minimally invasive interventions, increasing clinical adoption of shape-sensing flexible robotics, and the expanding need for early diagnostic tissue sampling in pulmonology and gastroenterology. Companies in this sector generate steady revenue streams through high-value capital console installations, recurring sales of proprietary single-use articulable catheter instruments, advanced software licensing, and comprehensive intraoperative maintenance and service contracts. Market leadership is defined by key industry players leveraging proprietary robotic platforms. Johnson & Johnson (Auris Health) maintains a strong commercial presence with its Monarch platform, which offers robotic-assisted bronchoscopy and urological navigation. Intuitive Surgical actively expands its footprint through the Ion endoluminal system for minimally invasive peripheral lung biopsy. Established endoscopy leaders like Olympus Corporation and Medtronic compete vigorously by integrating robotic navigation capabilities into their gastroenterology and surgical portfolios. Additionally, companies such as Asensus Surgical (acquired by KARL STORZ), CMR Surgical, and Brainlab contribute to market momentum through specialized flexible robotics, stereotactic tracking engines, and digital surgical ecosystems. Leading vendors are accelerating commercial expansion across North America, Europe, and high-growth Asia-Pacific markets while developing compact, modular consoles tailored for ambulatory surgical centers and outpatient diagnostic suites. Market Dynamics Market Drivers • Superior diagnostic yield and biopsy accuracy in hard-to-reach pathways: A primary driver for robotic endoscopy systems particularly in pulmonology and gastroenterology is their ability to overcome the structural limitations of conventional flexible scopes. Robotic platforms utilize shape-sensing technology, micro-articulation, and robotic stability to navigate deep into complex anatomical tracts, such as peripheral lung nodules or intricate gastrointestinal lumens. By maintaining precise trajectory control and filtering out physical hand tremors, robotic endoscopy dramatically improves diagnostic yield during tissue sampling, enabling clinicians to identify early-stage malignancies with higher confidence and fewer repeat procedures. • Clinical shift toward value-based care and reduced post-procedure complications: Healthcare systems worldwide are actively transitioning toward value-based care models that incentivize lower complication rates, shorter recovery times, and reduced hospital stays. Robotic-assisted endoscopic interventions offer sub-millimeter precision, enabling targeted tissue resection while minimizing surrounding operational trauma. The resulting reduction in post-operative adverse events such as accidental organ perforation or internal bleeding directly aligns with hospital cost-containment initiatives and optimizes bed turnover, making robotic endoscopy platforms an attractive investment for health systems looking to elevate clinical outcomes. Market Challenges • High capital expenditure and total cost of ownership: The steep initial investment required to purchase robotic endoscopy consoles poses a major financial restraint, particularly for mid-sized community hospitals, regional facilities, and providers in developing regions. Beyond the multi-million-dollar capital acquisition cost of the main robotic system, healthcare facilities face ongoing financial burdens including specialized single-use robotic catheter instruments, recurring software license updates, dedicated maintenance contracts, and infrastructure remodeling. Without clear, high-margin reimbursement pathways, justifying the return on investment remains a critical hurdle for procurement teams. • Steep learning curve and specialized physician training deficits: Operating sophisticated teleoperated or shape-sensing robotic endoscopy platforms demands specialized technical proficiency that differs significantly from traditional manual scope manipulation. Surgeons and gastroenterologists must undergo extensive simulation-based training, proctored clinical cases, and institutional credentialing to achieve mastery over console controls and spatial navigation software. A shortage of certified robotic training programs and the initial procedural slowdown associated with the physician learning curve slow down the rate of platform adoption across routine clinical workflows. Market Trends • Integration of AI-driven real-time guidance and computer vision: Robotic endoscopy is rapidly evolving from mechanical navigation toward intelligent, automated intraoperative guidance. Advanced deep-learning algorithms and computer vision are being directly integrated into robotic control systems to analyze live camera feeds. These AI models automatically assist clinicians by mapping optimal navigational pathways through airway or intestinal branches, highlighting suspicious mucosal lesions (such as polyps or early-stage carcinomas) in real time, and predicting tissue depth during therapeutic resections. • Convergence with single-use endoscopic instruments and modular ASC designs: To eliminate device-related cross-contamination and streamline hospital room turnarounds, manufacturers are increasingly designing robotic endoscopy platforms that utilize sterile, single-use articulable scope catheters. Concurrently, there is a strong design trend toward compact, modular robotic consoles tailored specifically for Ambulatory Surgical Centers (ASCs) and outpatient diagnostic suites. These portable, single-use-compatible robotic systems eliminate expensive central sterile processing requirements, allowing outpatient clinics to deliver high-precision robotic diagnostics with lower operational overhead. Segment Analysis The global robotic endoscopy market, segmented by product into diagnostic robotic endoscopes and therapeutic robotic endoscopes, is witnessing increasing development due to advancements in robotic technologies, growing demand for minimally invasive procedures, and the need for improved visualization and precision during endoscopic interventions. Diagnostic robotic endoscopes represent an important product category, as they support the examination of internal organs, identification of abnormalities, tissue visualization, and collection of biopsy samples. These systems are increasingly being explored for gastrointestinal, respiratory, and other diagnostic procedures, offering improved maneuverability, enhanced imaging, and greater control within complex anatomical pathways. Therapeutic robotic endoscopes are also gaining significant attention due to their ability to support interventions such as tissue removal, lesion treatment, endoscopic dissection, and other minimally invasive procedures. These systems incorporate advanced robotic controls and specialized instruments to improve procedural accuracy and instrument stability. Although diagnostic robotic endoscopes benefit from the established demand for endoscopic examinations and early disease detection, therapeutic robotic endoscopes are attracting growing interest as robotic technologies expand into more complex interventions. A notable market trend is the gradual transition from conventional diagnostic visualization toward multifunctional robotic platforms capable of supporting both diagnostic and therapeutic applications. Artificial intelligence, advanced imaging, flexible robotic instruments, and improved navigation capabilities are further enhancing system functionality. Additionally, manufacturers are focusing on developing compact and adaptable platforms that can be utilized across different clinical specialties. The global robotic endoscopy market, segmented by application into laparoscopy, bronchoscopy, colonoscopy, and other applications, is experiencing growing adoption due to increasing demand for minimally invasive procedures, improved surgical visualization, and enhanced instrument maneuverability. Laparoscopy represents an important and well-established application segment, supported by the increasing utilization of robotic technologies in abdominal surgeries, including hernia repair, gallbladder removal, colorectal procedures, and other general surgical interventions. Robotic-assisted laparoscopic systems enable surgeons to perform complex procedures with improved instrument control, precision, and visualization. Colonoscopy is another emerging application area, with robotic technologies being developed to improve navigation through the gastrointestinal tract, reduce procedural discomfort, and support effective examination of intestinal structures. Increasing awareness of colorectal cancer screening and early disease diagnosis is further encouraging innovation in robotic colonoscopy. Bronchoscopy is gaining attention through the development of robotic platforms that support navigation within complex airway structures, lung lesion localization, tissue sampling, and diagnostic interventions. These systems are particularly relevant for procedures requiring precise access to peripheral regions of the lungs. Other applications include specialized gastrointestinal, urological, and other endoscopic procedures. A significant market trend is the expansion of robotic endoscopy beyond conventional laparoscopic applications into flexible endoscopic procedures. Artificial intelligence, advanced imaging, computer-assisted navigation, and improved robotic instrument designs are supporting this transition. The global robotic endoscopy market, segmented by end user into hospitals, ambulatory surgical centers, and specialty clinics, is witnessing increasing adoption as healthcare providers integrate advanced robotic technologies into diagnostic and therapeutic procedures. Hospitals represent the largest and most prevalent end-user segment, primarily due to their extensive healthcare infrastructure, higher patient volumes, availability of specialized surgical departments, and greater financial capacity to invest in advanced robotic systems. Multispecialty hospitals and academic medical centers are important adoption centers, as they perform complex endoscopic procedures across gastrointestinal, respiratory, urological, and general surgical specialties. The availability of advanced operating rooms, skilled medical professionals, and specialized technical support further encourages robotic endoscopy adoption in these facilities. Ambulatory surgical centers represent an emerging end-user category, supported by the growing preference for outpatient procedures, shorter hospital stays, and cost-efficient healthcare delivery. The development of compact robotic platforms and advancements in minimally invasive technologies are creating opportunities for robotic endoscopy adoption in selected outpatient procedures. Specialty clinics are also gaining attention, particularly those focusing on gastroenterology, pulmonology, and other specialized diagnostic and therapeutic services. These facilities are increasingly exploring advanced endoscopic technologies to improve procedural accuracy, patient experience, and clinical efficiency. A notable market trend is the gradual expansion of robotic endoscopy from large hospital environments toward specialized outpatient healthcare facilities. Additionally, increasing investments in robotic infrastructure, surgeon training, and advanced visualization technologies are supporting broader adoption. Regional Analysis North America North America represents a prominent market for robotic endoscopy, supported by advanced healthcare infrastructure, high adoption of minimally invasive procedures, and significant investments in surgical robotics. The United States is a major contributor due to the presence of established medical technology companies, leading healthcare institutions, and increasing research activities. Growing demand for precision-based endoscopic procedures and advancements in robotic navigation and imaging technologies are further supporting regional market growth. Europe Europe holds a significant position in the robotic endoscopy market, driven by healthcare modernization, increasing adoption of advanced surgical technologies, and growing demand for minimally invasive interventions. Countries such as Germany, the United Kingdom, France, and Italy are important contributors. Strong medical research capabilities, established healthcare systems, and increasing investments in robotic-assisted procedures are supporting regional development. Asia Pacific Asia Pacific is emerging as a rapidly developing market, supported by expanding healthcare infrastructure, rising healthcare expenditure, and increasing adoption of advanced medical technologies. China, Japan, India, and South Korea are important contributors to regional growth. Growing medical tourism, increasing investments in specialized hospitals, and rising demand for advanced gastrointestinal and respiratory procedures are creating opportunities for robotic endoscopy manufacturers. South America South America is witnessing gradual growth in the robotic endoscopy market, driven by improvements in healthcare infrastructure and increasing investments in modern surgical technologies. Brazil and Argentina represent important regional markets, supported by expanding private healthcare facilities and growing awareness of minimally invasive procedures. However, high equipment costs, limited access to specialized technologies, and budget constraints remain challenges affecting widespread adoption. Middle East and Africa The Middle East and Africa market is gradually developing, supported by healthcare infrastructure modernization, government-led healthcare investments, and increasing demand for specialized diagnostic and surgical services. Saudi Arabia and the United Arab Emirates are contributing to regional development through investments in advanced hospitals and robotic surgical technologies, while South Africa represents an important market in Africa. Growing medical tourism, healthcare digitalization, and increasing adoption of minimally invasive procedures are creating further opportunities for market expansion. Key Developments • May 2026: Olympus Corporation signed an exclusive global distribution agreement with EndoRobotics Co., Ltd. to add robot-assisted technologies under the Olympus EndoTherapy portfolio. The deal uses Olympus's installed-base reach in GI endoscopy to commercialize specialized robotics faster and strengthens bundling of devices and procedure accessories through a single procurement channel. • July 2025: Olympus Corporation and Revival Healthcare Capital established Swan EndoSurgical to develop endoluminal robotic systems for gastrointestinal patient care, with a combined investment commitment of up to USD 458 million. This vehicle formalizes long-horizon R&D and commercialization funding for endoluminal robotics, increasing competitive pressure on incumbents that rely solely on internal development. • August 2024: Asensus Surgical completed its acquisition by the KARL STORZ Group, making Asensus a wholly owned subsidiary. The combination links a surgical robotics platform with a major endoscopy and visualization franchise, tightening integration across instruments, imaging, and digital workflow components used in minimally invasive procedures. Considered in this report • Historic Year: 2020 • Base Year: 2025 • Estimated Year: 2026 • Forecast Year: 2031 Aspects covered in this report • Global Robotic Endoscopy Market with its value and forecast along with its segments • Various drivers and challenges • Ongoing trends and developments • Top profiled companies • Strategic recommendation By Product • Diagnostic Robotic Endoscopes • Therapeutic Robotic Endoscopes By Application • Laparoscopy • Bronchoscopy • Colonoscopy • Other Applications By End User • Hospitals • Ambulatory Surgical Centers • Specialty Clinics

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Ask an Expert

Sikandar Kesari

Research Analyst

Don't pay for what you don't need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now